Resverlogix Corp. (RVX.TO)
0.10
0.00 (0.00%)
CAD |
TSX |
Aug 26, 14:40
Resverlogix Shareholders Equity (Quarterly) : -133.75M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -133.75M |
| March 31, 2026 | -125.95M |
| December 31, 2025 | -121.94M |
| September 30, 2025 | -123.69M |
| June 30, 2025 | -120.23M |
| March 31, 2025 | -124.73M |
| December 31, 2024 | -117.55M |
| September 30, 2024 | -111.41M |
| June 30, 2024 | -106.15M |
| March 31, 2024 | -98.91M |
| December 31, 2023 | -98.20M |
| September 30, 2023 | -96.71M |
| June 30, 2023 | -88.96M |
| March 31, 2023 | -86.52M |
| December 31, 2022 | -80.32M |
| September 30, 2022 | -82.74M |
| June 30, 2022 | -77.42M |
| March 31, 2022 | -75.72M |
| December 31, 2021 | -75.62M |
| September 30, 2021 | -55.13M |
| June 30, 2021 | -47.86M |
| March 31, 2021 | -49.27M |
| January 31, 2021 | |
| October 31, 2020 | |
| July 31, 2020 |
| Date | Value |
|---|---|
| April 30, 2020 | -89.05M |
| January 31, 2020 | -98.97M |
| October 31, 2019 | -107.90M |
| July 31, 2019 | -255.15M |
| April 30, 2019 | -279.43M |
| January 31, 2019 | -205.48M |
| October 31, 2018 | -204.60M |
| July 31, 2018 | -173.03M |
| April 30, 2018 | -107.27M |
| January 31, 2018 | -96.28M |
| October 31, 2017 | -153.20M |
| July 31, 2017 | -139.10M |
| April 30, 2017 | -138.88M |
| January 31, 2017 | -117.96M |
| October 31, 2016 | -104.15M |
| July 31, 2016 | -81.64M |
| April 30, 2016 | -70.68M |
| January 31, 2016 | -66.27M |
| October 31, 2015 | -50.30M |
| July 31, 2015 | -45.40M |
| April 30, 2015 | -89.30M |
| January 31, 2015 | -69.78M |
| October 31, 2014 | -60.22M |
| July 31, 2014 | -58.79M |
| April 30, 2014 | -69.38M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Spectral Medical, Inc. | -70.07M |
| Theratechnologies, Inc. | -38.39M |
| COSCIENS Biopharma, Inc. | 21.06M |
| Restart Life Sciences Corp. | 1.543M |
| Defence Therapeutics Inc | 5.415M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 11.71M |
| Total Liabilities (Quarterly) | 145.46M |
| Debt to Equity Ratio | -0.8247 |
| Current Ratio | 0.0392 |
| Net Debt Paydown Yield | -1.83% |